The Paragon Report Provides Stock Research on China Mobile and Ctrip.com
Continue ReadingTag: analyst-reports
Improving Trend in FDA First Cycle Review Approvals a Major Factor for Biotech Industry-s Success in 2012
Five Star Equities Provides Stock Research on Alexza Pharmaceuticals and EntreMed
Continue ReadingChinese Equities Receive a Boost as Manufacturing in China Rises for the First Time in 13 Months
The Paragon Report Provides Stock Research on Cleantech Solutions International and Zhongpin
Continue ReadingConsumer Spending Could Drop by as Much as $200 Billion if Upcoming “Fiscal Cliff” Is Not Avoided
The Paragon Report Provides Stock Research on The Coca-Cola and Mondelez International
Continue ReadingChina to Provide Subsidies to Rare Earth Producers in Attempts to Boost Struggling Industry
Five Star Equities Provides Stock Research on Lynas and Quest Rare Minerals
Continue ReadingDemand for Rare Earths Expected to Top 200,000 Tons by 2020 — Molycorp Shares Surge as Executives Purchase Shares
Five Star Equities Provides Stock Research on Molycorp and Rare Element Resources
Continue ReadingBiotech Industry Skyrockets in 2012 as FDA New Drug Approval Rate Increases
Five Star Equities Provides Stock Research on Cytokinetics and Galectin Therapeutics
Continue ReadingGuidelines of New “Stress Tests” Announced – Focused on the Handling of Major Recessions in China and Europe
Five Star Equities Provides Stock Research on U.S. Bancorp and Hudson City Bancorp
Continue ReadingU.S. Forecasted by the IEA to Be the World-s Top Oil Producer by 2020
The Paragon Report Provides Stock Research on Goodrich Petroleum and Talisman Energy
Continue ReadingBiotech Industry Experiencing a Higher Amount of FDA New Drug Approvals in 2012
Five Star Equities Provides Stock Research on Discovery Laboratories and Cardium Therapeutics
Continue Reading